bioRxivMicrobiologyPreprint
High titers of multiple antibody isotypes against the SARS-CoV-2 spike receptor-binding domain and nucleoprotein associate with better neutralization.
M. G. Noval, M. E. Kaczmarek, A. Koide, B. A. Rodriguez-Rodriguez, P. Louie, T. Tada, T. Hattori, T. Panchenko, L. A. Romero, K. W. Teng, A. Bazley, M. de Vries, M. I. Samanovic, J. N. Weiser, I. Aifantis, J. Cangiarella, M. J. Mulligan, L. Desvignes, M. Dittmann, N. R. Landau, M. E. Aguero-Rosenfeld, S. Koide, K. A. Stapleford
Abstract
Understanding antibody responses to SARS-CoV-2 is indispensable for the development of containment measures to overcome the current COVID-19 pandemic. Here, we determine the ability of sera from 101 recovered healthcare workers to neutralize both authentic SARS-CoV-2 and SARS-CoV-2 pseudotyped virus and address their antibody titers against SARS-CoV-2 nucleoprotein and spike receptor-binding domain. Interestingly, the majority of individuals have low neutralization capacity and only 6% of the healthcare workers showed high neutralizing titers against both authentic SARS-CoV-2 virus and the pseudotyped virus. We found the antibody response to SARS-CoV-2 infection generates antigen-specific isotypes as well as a diverse combination of antibody isotypes, with high titers of IgG, IgM and IgA against both antigens correlating with neutralization capacity. Importantly, we found that neutralization correlated with antibody titers as quantified by ELISA. This suggests that an ELISA assay can be used to determine seroneutralization potential. Altogether, our work provides a snapshot of the SARS-CoV-2 neutralizing antibody response in recovered healthcare workers and provides evidence that possessing multiple antibody isotypes may play an important role in SARS-CoV-2 neutralization.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comparative analysis of antigen-specific anti-SARS-CoV-2 antibody isotypes in COVID-19 patients
H. Fujigaki, M. Inaba, … K. Saito·bioRxiv·Dec 4, 2020
- Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples
L. Mazzini, D. Martinuzzi, … E. Montomoli·bioRxiv·Aug 10, 2020
- Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples
S. E. Larsen, B. J. Berube, … R. N. Coler·bioRxiv·Jul 2, 2021
- Limited variation between SARS-CoV-2-infected individuals in domain specificity and relative potency of the antibody response against the spike glycoprotein
H. A. Van Ert, D. W. Bohan, … H. Haim·bioRxiv·Aug 4, 2021
- SARS-CoV-2 Neutralizing Antibody Responses Are More Robust in Patients with Severe Disease
P. Wang, L. Liu, … D. D. Ho·Emerging Microbes & InfectionsPeer-reviewed·Sep 25, 2020
- Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2
K. Vanshylla, V. Di Cristianziano, … F. Klein·bioRxiv·Jan 26, 2021